Want to take quizzes and track your credits?
In late March 2020, the Centers for Medicare & Medicaid Services (CMS) released projections of US national health spending that predicted growth from the 2019 level of 17.8% of gross domestic product (GDP) to 19.7% over the next 10 years.1 Through no fault of their own, the CMS prognosticators are poised to take their place in history beside economist Irving Fischer, who announced that “stock prices have reached what looks like a permanently high plateau” shortly before the market crash of 1929 that marked the start of the Great Depression. The coronavirus disease 2019 (COVID-19) pandemic is likely to result in year-over-year changes in both health care spending and GDP that are without precedent. Because the ratio of these 2 numbers, the share of health care in the GDP, receives so much attention in public policy, it is worth thinking about how large these changes may be, and more importantly, what they mean.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Sherry Glied, PhD, Robert F. Wagner Graduate School of Public Service, New York University, 295 Lafayette St, Second Floor, New York, NY 10012 (firstname.lastname@example.org).
Published Online: April 27, 2020. doi:10.1001/jama.2020.6644
Conflict of Interest Disclosures: Dr Glied reported receiving fees from and being a director of NeuroRx, a company with an interest in patent 8178489 for aviptadil, which is in a clinical trial for treatment of acute respiratory distress syndrome in COVID-19 patients. Dr Levy reported receiving personal fees from the FAIR Health Academic Advisory Board.
You currently have no searches saved.